We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
-1.25%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$26.9B
AUM Growth
-$472M
Cap. Flow
+$303M
Cap. Flow %
1.12%
Top 10 Hldgs %
7.59%
Holding
1,412
New
295
Increased
487
Reduced
400
Closed
230

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$190M
2
INTC icon
Intel
INTC
+$149M
3
MRK icon
Merck
MRK
+$140M
4
BKNG icon
Booking.com
BKNG
+$139M
5
V icon
Visa
V
+$134M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$290M
2
META icon
Meta Platforms (Facebook)
META
+$285M
3
JD icon
JD.com
JD
+$270M
4
PG icon
Procter & Gamble
PG
+$184M
5
HUM icon
Humana
HUM
+$176M

Sector Composition

Rank Sector Weight
1 Technology 18.35%
2 Industrials 14.76%
3 Consumer Discretionary 14.76%
4 Financials 13.95%
5 Healthcare 13.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
1176
MiMedx Group
MDXG
$630M
$183K ﹤0.01%
26,465
-3,521
-12% -$24.8K
BDN
1177
Brandywine Realty Trust
BDN
$534M
$164K ﹤0.01%
36,617
-78,538
-68% -$358K
CATX icon
1178
Perspective Therapeutics
CATX
$363M
$159K ﹤0.01%
+15,963
New +$231K
ATEC icon
1179
Alphatec Holdings
ATEC
$1.45B
$154K ﹤0.01%
14,776
-122,477
-89% -$1.43M
CGC
1180
Canopy Growth
CGC
$422M
$140K ﹤0.01%
+21,648
New +$186K
SPRY icon
1181
ARS Pharmaceuticals
SPRY
$591M
$88.4K ﹤0.01%
+10,388
New +$92.2K
TMCI icon
1182
Treace Medical Concepts
TMCI
$308M
$84.4K ﹤0.01%
12,690
-161,982
-93% -$1.31M
ABCL icon
1183
AbCellera Biologics
ABCL
$2.99B
-13,448
Closed -$60.9K
ABR icon
1184
Arbor Realty Trust
ABR
$998M
-119,759
Closed -$1.59M
AFRM icon
1185
Affirm
AFRM
$25.7B
-598,836
Closed -$22.3M
ALGM icon
1186
Allegro MicroSystems
ALGM
$7.93B
-77,669
Closed -$2.09M
AMAT icon
1187
Applied Materials
AMAT
$417B
-53,099
Closed -$11M
AMD icon
1188
Advanced Micro Devices
AMD
$774B
-189,229
Closed -$34.2M
AMGN icon
1189
Amgen
AMGN
$224B
-30,383
Closed -$8.64M
ANIP icon
1190
ANI Pharmaceuticals
ANIP
$1.71B
-13,346
Closed -$923K
AOS icon
1191
A.O. Smith
AOS
$8.65B
-16,870
Closed -$1.51M
APD icon
1192
Air Products & Chemicals
APD
$68.9B
-136,496
Closed -$33.1M
APH icon
1193
Amphenol
APH
$206B
-586,436
Closed -$33.8M
APOG icon
1194
Apogee Enterprises
APOG
$904M
-23,618
Closed -$1.4M
APPN icon
1195
Appian
APPN
$2.54B
-8,633
Closed -$345K
APTV icon
1196
Aptiv
APTV
$10.3B
-456,461
Closed -$36.4M
ASIX icon
1197
AdvanSix
ASIX
$452M
-24,892
Closed -$712K
ATHM icon
1198
Autohome
ATHM
$2.65B
-13,015
Closed -$341K
AZN icon
1199
AstraZeneca
AZN
$246B
-424,397
Closed -$57.5M
BAH icon
1200
Booz Allen Hamilton
BAH
$9.45B
-20,313
Closed -$3.02M

Similar funds

Voloridge Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Voloridge Investment Management held 1,412 positions worth $26.9B, down 1.7% from $27.4B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Voloridge Investment Management's Q2 2024 filing shows 295 new, 487 increased, 400 reduced and 230 closed positions. Its largest new stake was Pinduoduo: 1,405,825 shares worth $187M. The largest sale was Apple, an estimated $290M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Voloridge Investment Management's largest Q2 2024 buy was Pinduoduo: 1,405,825 shares worth $187M.
  • Voloridge Investment Management added most to Merck in Q2 2024, an estimated $140M increase.
  • Voloridge Investment Management's biggest Q2 2024 reduction was Apple, cutting an estimated $290M.
  • Voloridge Investment Management fully exited Deere & Co in Q2 2024, selling an estimated $171M.
  • Voloridge Investment Management's ten largest holdings make up 7.6% of its $26.9B portfolio in Q2 2024.
  • Voloridge Investment Management opened 295 new positions and closed 230 in Q2 2024.
  • Voloridge Investment Management's portfolio value fell 1.7% quarter-over-quarter to $26.9B.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.